Tradestie Institutional Equity Comparison Engine

NVS vs MRK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NVS Overall Edge

NVS Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Novartis AG (NVS) driven by superior Valuation, Growth & Margin, Options & Structure while MRK counters with relative strength in Momentum & Technical. Fundamentally, NVS trades at 16.2x Forward P/E with 34.0% operating margin (+4.7% YoY revenue) versus MRK at 16.4x Forward P/E and 35.2% operating margin (+4.7% YoY). In options structure, NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro) against MRK sits in CONSOLIDATION (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NVS
NVS 16.2x vs MRK 16.4x Fwd P/E
Growth & Margin Winner NVS
Op Margin 34.0% vs 35.2% ยท YoY +4.7% vs +4.7%
Momentum & Technical Winner MRK
1Y +22.5% vs +57.5% ยท 52W Pos 81% vs 84%
Options & Structure Winner NVS
UNCLASSIFIED (6th %ile IV) vs CONSOLIDATION (100th %ile IV)
NVS NYSE
Novartis AG
Pharmaceutical Preparations
$161.59
+0.68% 1D
Market Cap $302.9B
1M Return +7.28%
1Y Return +22.5%
Forward P/E 16.2x
Unified AI Score
41.5 / 100 SELL
Tech 29.0 Fund 38.0 Flow 50.0 Mom 21.1
MRK NYSE
Merck & Co., Inc.
Pharmaceutical Preparations
$146.35
-0.95% 1D
Market Cap $362.3B
1M Return +0.27%
1Y Return +57.48%
Forward P/E 16.4x
Unified AI Score
57.1 / 100 HOLD
Tech 48.0 Fund 65.0 Flow 67.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NVS +22.5% MRK +57.48% Spread: +34.98 pp (MRK Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NVS TTM Op. Margin: 34.0% MRK TTM Op. Margin: 35.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NVS vs MRK. Trailing 12-month operating profitability (NVS 34.0% vs MRK 35.2%) and valuation multiples (NVS 16.2x vs MRK 16.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NVS (5) vs MRK (4)
Institutional Metric NVS MRK Criterion Row Winner
Market Capitalization Scale $302.9B $362.3B Larger Scale MRK
Trailing P/E Ratio Valuation 30.6x 148.4x Lower Multiple NVS
Forward P/E Ratio Valuation 16.2x 16.4x Lower Multiple NVS
Revenue Growth (YoY) Growth +4.7% +4.7% Higher Growth Tie
Operating Margin (TTM) Profitability 34.0% 35.2% Higher Margin MRK
Net Profit Margin Profitability 17.5% 3.6% Higher Margin NVS
Return on Equity (ROE) Capital Efficiency 24.3% 5.1% Higher ROE NVS
52-Week Range Position Momentum 81% ($123โ€“$170) 84% ($91โ€“$157) Stronger Trend MRK
Beta / 30D Volatility Risk Regime 0.31ฮฒ ยท 27% Vol 0.19ฮฒ ยท 31% Vol Lower Realized Risk NVS
Unified Institutional Score Composite Signal 41.5 / 100 (SELL) 57.1 / 100 (HOLD) Higher Composite MRK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NVS vs MRK Buy Guide
NVS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live NVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MRK CONSOLIDATION
57d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live MRK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NVS nor MRK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.